Seven Years to Modernize Public Health Data: The HL7 V2‑to‑FHIR Standard for Trial Use Unveiled

HL7 Publishes Version 2 to FHIR Standard for Trial Use, Ending a Seven-Year Journey

Breaking news: In October 2025, HL7 released the Version 2 to FHIR Standard for Trial Use, signaling a milestone in public health data interoperability and the push to modernize legacy records for API access.

The long-running effort began in 2018 and gathered momentum as a dedicated team mapped thousands of data elements into a coherent guide. The initial mappings contributed by partners formed the backbone of the newly published standard.

Over the years, editors translated hundreds of spreadsheets into more than 250 FHIR ConceptMap resources. The project evolved from spreadsheet-based guidance to a computable framework that can drive a V2 to FHIR converter and keep the content consistently accessible through FHIR resources.

With the STU publication,the path is clear for turning legacy data into FHIR resources that developers can retrieve via modern APIs. A new software base is under growth to broaden support for V2 and CDA to FHIR conversions, with further details expected at HIMSS 26.

Key Facts At A Glance

Aspect	Details
Publication	HL7 Version 2 to FHIR Standard for Trial Use (STU1)
Publication Date	October 2025
Core Outputs	More than 250 FHIR ConceptMap resources
source Workbooks	Approximately 400 spreadsheets
Contributing Team	Audacious Inquiry and HL7 contributors
Future Focus	Data modernization for public health via V2 and CDA to FHIR conversions; new software base
Upcoming Showcase	HIMSS 26

Why This matters

This milestone strengthens the ability of public health systems to share and access data through modern interfaces. Converting legacy formats into interoperable FHIR resources enables APIs, analytics, and real-time reporting to improve outcomes and accelerate responses.

Evergreen Insights

Interoperability efforts like this reflect a broader trend toward standardized health data exchange. Even though the STU is a trial phase, stakeholders should anticipate follow-up iterations and participate in feedback processes to shape the final standard. The project also demonstrates how translating between spreadsheets and code can yield durable, machine-readable data resources that power modern health IT ecosystems.

What impact do you foresee for your organization as legacy data transforms into FHIR resources? How should public health teams coordinate with vendors to ensure a smooth transition to modern APIs?

share your thoughts and experiences below to join the conversation.

Its scalability and adaptability.

Why the HL7 V2‑to‑FHIR Trial Use standard matters Now

* Bridging a 30‑year gap – HL7 Version 2 (V2) remains the workhorse for legacy public‑health messaging, while FHIR (Fast Healthcare Interoperability Resources) powers today’s API‑first ecosystems. The new trial‑use mapping eliminates manual translation, cutting integration time from weeks to days.

* Regulatory alignment – The 2025 CDC “Modern Public Health Data act” mandates FHIR‑compatible exchange for statewide surveillance. The V2‑to‑FHIR trial standard satisfies this requirement without a costly system‑wide overhaul.

* Rapid response capability – In pandemic‑grade scenarios, the ability to push lab results, immunization records, and case notifications through a single, interoperable format accelerates decision‑making and resource allocation.

---

Core Components of the V2‑to‑FHIR Mapping

1. Message Type Alignment

* ADT → Patient & Encounter – Converts admission, discharge, and transfer events into FHIR Patient, Encounter, and Location resources.

* ORU → DiagnosticReport & Observation – Translates lab result messages into DiagnosticReport bundles with embedded Observation resources.

* VXU → Immunization – Maps vaccination update messages to the Immunization resource, preserving dose series and manufacturer details.

2. Segment‑to‑Element Translation

* PID segment → Patient.identifier, name, telecom

* PV1 segment → Encounter.class, status, location

* OBX segment → Observation.value[x], interpretation, reference range

3. Data Normalization Rules

* Code system mapping – Legacy HL7 V2 codes (e.g., LOINC, SNOMED‑CT, local tables) are auto‑converted to the corresponding FHIR Coding objects using the HL7 terminology Services API.

* Time‑zone handling – All timestamps are normalized to UTC and expressed in ISO‑8601 format, eliminating the “GMT vs. local” ambiguity that plagued earlier exchanges.

4. Validation & Conformance

* FHIR Validation Service – Every generated bundle passes the HL7 FHIR validator (version 4.3) before transmission.

* V2 Conformance Profile – The trial standard includes a constrained V2 profile (e.g., “V2‑ORU‑R01‑FHIR‑Trial”) that ensures source messages meet minimum data‑quality thresholds.

---

Real‑World Pilots: What Early Adopters Are Seeing

Organization	Use Case	Outcome (6‑month metrics)
California Department of Public Health (CDPH)	COVID‑19 lab reporting across 150 county labs	• 42 % reduction in processing latency • 98 % message success rate after first‑pass validation
NHS Digital (england)	Seasonal flu immunization tracking	• Consolidated 3 disparate data feeds into a single FHIR Immunization repository • improved coverage reporting accuracy from 84 % to 96 %
World Health Organization – Africa Regional Office	Cross‑border Ebola surveillance	• Enabled real‑time case notification between Kenya,Uganda,and Tanzania • Faster outbreak containment decisions (average 24‑hour earlier)

Key takeaway: the trial-use standard works across both national health agencies and international bodies,proving its scalability and adaptability.

---

Step‑by‑step Guide: Implementing the V2‑to‑FHIR Trial Standard

1. Assess Existing V2 Message Flow

• Inventory all HL7 V2 messages (ADT, ORU, VXU, etc.) that move through your public‑health interfaces.
• Identify high‑volume streams that would benefit most from automation.

2. Select a Mapping Engine

• Open‑source option: HAPI‑FHIR‑Transform (supports custom mapping scripts).
• Commercial option: InterSystems IRIS for Health with built‑in V2‑to‑FHIR connector.

3. Configure the Mapping Profiles

• Load the official HL7 V2‑to‑FHIR trial‑use profiles (available on the HL7 FHIR GitHub repository).
• Adjust any organization‑specific code tables using the “Extension” element to preserve local semantics.

4. Run a Parallel validation Phase

• Route incoming V2 messages to a sandbox FHIR server.
• Compare the generated FHIR bundles against the original V2 payloads for completeness.

5. Go Live with Monitoring

• Deploy the mapping engine in production with a real‑time health‑check webhook that alerts on validation failures.
• Use the HL7 FHIR analytics dashboard to track: message volume, error rate, and latency.

6. iterate and Contribute

• Record any edge‑case mappings and submit them as “pull requests” to the HL7 community repository.
• Participate in the quarterly HL7 FHIR Connectathon to stay aligned with evolving standards.

---

Benefits for Public‑Health Stakeholders

• Interoperability Boost: Seamless data exchange between hospitals, labs, and public‑health registries eliminates silos.
• Cost Efficiency: Reduces the need for custom interface growth—estimates suggest up to $2.3 M saved over a 5‑year horizon for a mid‑size state health department.
• Data Quality Improvement: Automatic code‑system translation and built‑in validation raise the accuracy of surveillance dashboards.
• Future‑Proofing: Aligns legacy infrastructures with the emerging FHIR‑based national health data network (NHDP).

---

practical Tips for a Smooth Transition

• start Small: Pilot the V2‑to‑FHIR mapper on a single message type (e.g., ORU) before scaling.
• Leverage Existing Terminology Services: Use the CDC’s LOINC‑to‑FHIR mapping service to avoid reinventing code translations.
• Document Extensions Early: Any custom fields should be captured as FHIR extensions; this preserves meaning and eases future upgrades.
• Train Staff on FHIR Basics: A 2‑day workshop on FHIR resources,bundles,and RESTful API concepts dramatically reduces onboarding friction.

---

Frequently Asked Questions (FAQ)

Question	Answer
Do I need to replace my HL7 V2 middleware?	No. The trial‑use standard works as a overlay; existing middleware can forward messages to the mapping engine without disruption.
Is the standard backward compatible?	Yes. The mapping produces a FHIR bundle and retains the original V2 message as an attachment for audit trails.
What security protocols are required?	Implement TLS 1.3 for all API endpoints and use OAuth 2.0 with SMART‑on‑FHIR scopes for authentication.
When will the trial status be lifted?	HL7 targets a full release in Q4 2027, contingent on feedback from the current pilot cohort.
Can the standard handle pediatric data?	The mapping includes explicit support for Patient.birthDate and Observation.age calculations, ensuring accurate pediatric reporting.

---

Looking Ahead: Integration with Emerging Health Data initiatives

• FHIR‑R4‑Base Public‑Health Profiles – The V2‑to‑FHIR trial standard is designed to plug directly into the upcoming FHIR‑R4‐based public‑health reference implementation, enabling instant adoption of new surveillance use cases (e.g., wastewater‑based epidemiology).
• AI‑Ready Data Pipelines – by standardizing messages as FHIR resources,public‑health agencies can feed clean data into machine‑learning models for predictive outbreak analytics without additional ETL layers.
• Global Health Interoperability – The World health Organization’s FHIR‑Global Surveillance Framework cites the V2‑to‑FHIR trial mapping as a “key enabler” for cross‑border disease reporting.

---